SJOGREN'S SYNDROME
Clinical trials for SJOGREN'S SYNDROME explained in plain language.
Never miss a new study
Get alerted when new SJOGREN'S SYNDROME trials appear
Sign up with your email to follow new studies for SJOGREN'S SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on lupus and other autoimmune diseases
Disease control Recruiting nowThis study tests a new treatment using specially engineered immune cells (CAR-T) to target and calm overactive immune cells in people with autoimmune diseases like lupus, scleroderma, and Sjogren's syndrome. About 20 adults aged 18 to 70 with active disease will receive either CD…
Matched conditions: SJOGREN'S SYNDROME
Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 01:29 UTC
-
New cell therapy trial aims to tame tough autoimmune diseases
Disease control Recruiting nowThis early-stage study tests a new cell treatment called YTS109 in 18 adults with hard-to-treat autoimmune diseases like lupus and Sjogren's syndrome. The main goal is to check if the treatment is safe, and also to see if it helps control the disease. Participants receive a singl…
Matched conditions: SJOGREN'S SYNDROME
Phase: PHASE1 • Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Could a rheumatoid arthritis drug tame Sjogren's symptoms?
Disease control Recruiting nowThis study tests whether tofacitinib, a pill already approved for rheumatoid arthritis, is safe for people with Sjogren's disease. About 60 adults with mild-to-moderate Sjogren's will take the drug twice daily for 28 weeks. Researchers will monitor side effects and check for impr…
Matched conditions: SJOGREN'S SYNDROME
Phase: PHASE2 • Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New shot for Sjogren's disease enters early human testing
Disease control Recruiting nowThis early-stage study tests a new drug, CLN-978, given as a shot under the skin for people with active, moderate to severe Sjogren's disease. The main goal is to check safety and side effects, and it will also measure how the drug works in the body and affects immune cells. Abou…
Matched conditions: SJOGREN'S SYNDROME
Phase: PHASE1 • Sponsor: Cullinan Therapeutics Inc. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New drug trial aims to tame autoimmune diseases
Disease control Recruiting nowThis early-stage study tests a new drug, SAR448501/DR-0201, in 62 adults with lupus or rheumatoid arthritis. The goal is to find the safest and most effective dose by checking side effects and how the drug works in the body. Participants will be followed for about 13 months, and …
Matched conditions: SJOGREN'S SYNDROME
Phase: PHASE1 • Sponsor: Sanofi • Aim: Disease control
Last updated May 04, 2026 16:24 UTC
-
Online wellness program aims to ease fatigue in rheumatic disease patients
Symptom relief Recruiting nowThis study tests whether an online program that teaches better diet and self-care can reduce fatigue and improve quality of life for adults with rheumatoid arthritis, Sjogren's syndrome, lupus, mixed connective tissue disease, or psoriatic arthritis. About 200 participants will u…
Matched conditions: SJOGREN'S SYNDROME
Phase: NA • Sponsor: Terry L. Wahls • Aim: Symptom relief
Last updated May 11, 2026 20:38 UTC
-
NIH launches study to unravel Sjogren's mystery
Knowledge-focused Recruiting nowThis study follows 300 people with Sjogren's disease (or symptoms) over several visits to learn how the condition starts and changes. Researchers collect saliva, blood, and eye tests, and ask about symptoms. The goal is to find clues for better treatments, not to test a new thera…
Matched conditions: SJOGREN'S SYNDROME
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Knowledge-focused
Last updated May 17, 2026 01:19 UTC
-
AI steps in to catch hidden dangers of rheumatoid arthritis
Knowledge-focused Recruiting nowThis study looks at whether generative AI can help doctors better diagnose complications of rheumatoid arthritis (RA), such as lung disease or heart problems. Researchers will use AI to analyze patient records and suggest possible complications, then see if doctors find these sug…
Matched conditions: SJOGREN'S SYNDROME
Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences • Aim: Knowledge-focused
Last updated May 17, 2026 01:18 UTC
-
New registry aims to unlock secrets of autoimmune disease in pregnancy
Knowledge-focused Recruiting nowThis study is creating a registry of 1,000 pregnant women with autoimmune diseases like lupus and rheumatoid arthritis. Researchers will track their health and pregnancy outcomes to identify risk factors and ways to improve care for both mothers and babies. The study does not tes…
Matched conditions: SJOGREN'S SYNDROME
Sponsor: Duke University • Aim: Knowledge-focused
Last updated May 17, 2026 01:18 UTC
-
Thousands join study to unlock secrets of arthritis and lupus
Knowledge-focused Recruiting nowThis study is building a large database and sample bank from 5,000 adults with various rheumatic diseases like rheumatoid arthritis, lupus, and psoriatic arthritis. Researchers will use this information to find links between patient outcomes and biological markers. The goal is to…
Matched conditions: SJOGREN'S SYNDROME
Sponsor: Yale University • Aim: Knowledge-focused
Last updated May 17, 2026 01:17 UTC
-
Scientists seek answers for salivary gland disorders
Knowledge-focused Recruiting nowThis study aims to learn more about diseases that affect the salivary glands, which produce saliva. Researchers will collect medical information, blood, saliva, and tissue samples from people with these conditions, their relatives, and healthy volunteers. The goal is to better un…
Matched conditions: SJOGREN'S SYNDROME
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Knowledge-focused
Last updated May 17, 2026 01:16 UTC
-
Lab study tests cannabis compounds on immune cells from arthritis and lupus patients
Knowledge-focused Recruiting nowThis study looks at how natural cannabis compounds (phytocannabinoids) affect immune cells from 100 people with chronic inflammatory diseases like rheumatoid arthritis, lupus, and inflammatory bowel disease. Researchers will take blood samples and expose the cells to different ca…
Matched conditions: SJOGREN'S SYNDROME
Sponsor: Centre Hospitalier Régional d'Orléans • Aim: Knowledge-focused
Last updated May 13, 2026 16:02 UTC
-
New scan could reveal hidden inflammation in Sjögren's patients
Knowledge-focused Recruiting nowThis study is testing whether a special PET scan called FAPI PET/CT can see inflammation in people with Sjögren's syndrome, an autoimmune disease that causes dryness. Researchers will compare the scan results with blood tests and also look at scans from people with tumors. The go…
Matched conditions: SJOGREN'S SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated May 07, 2026 18:41 UTC